MGMT and neoplasm: We postulate that multi-omics data integration can capture multi-faceted tumor characteristics at different scales, i.e., molecular (genomics and MGMT methylation), macroscopic (radiomics), and clinical, and therefore provide the clinicians with a comprehensive representation of the patient’s condition and risk, towards facilitating personalized treatment planning and more efficient clinical trial stratification.